Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Schedule your consultation today to learn if this treatment is right for you
Research shows modest, incremental HbA1c reductions (typically 0.30.8%) when adding a DPP-4 inhibitor to a GLP-1 drug, but many patients achieve superior glucose control by simply increasing their GLP-1 dose or switching to a dual-agonist like tirzepatide
G0108 for individual DSMT sessions, G0109 for group sessions
The combined anti-inflammatory effect could accelerate the metabolic improvements that take weeks or months to manifest with either compound alone
US$ 25.35
US$ 21.46
US$ 22.41
US$ 28.63
US$ 21.77
